Sechenov School
Home › Pathology › Nucleoprotein Metabolism Disorders

Nucleoprotein Metabolism Disorders

*Podagra*

For medical students2 min readUpdated 2026-10-10

Pathology of nucleoprotein metabolism disorders is a key topic studying disruptions in purine metabolism. These pathological processes are driven by an imbalance between the production and excretion of uric acid. The cornerstone of pathogenesis is hyperuricemia, which inevitably leads to crystal precipitation in various tissues. Clinically and morphologically, this condition manifests as gout, urate nephrolithiasis, or uric acid infarct.

Molecular BasisNucleoproteins are complexes of proteins and nucleic acids (DNA and RNA).
Excretion PathwayThe end products of purine metabolism (uric acid) are normally excreted by the kidneys.
Main MarkerHyperuricemia is a pathologically elevated concentration of uric acid in the blood.
Essence of GoutIntermittent precipitation of monosodium urate crystals in joints, causing pain.

Physiological Basis of Nucleoprotein Metabolism

To understand the pathology, one must first review normal physiology. Nucleoproteins are complex macromolecules composed of two main components: a protein moiety and nucleic acids, namely DNA and RNA.

These substances enter the human body via two pathways. The exogenous pathway involves dietary intake, while the endogenous pathway represents the body's autonomous synthesis of necessary nucleoproteins for cellular building blocks.

During cellular turnover, nucleic acids undergo metabolism, a process also known as purine metabolism. Its end products are invariably uric acid and its specific salts. In a healthy organism, these breakdown products do not accumulate: they enter the bloodstream, undergo filtration, and are successfully excreted by the kidneys.

Pathogenesis: How the System Fails

Nucleoprotein metabolism disorders never arise spontaneously; they follow a precise cascade. Pathogenesis involves three sequential stages, each compounding the previous one:

  1. Excessive production of uric acid. At this stage, the balance is disrupted: purine metabolism accelerates, or their utilization system fails, leading to an overabundance of the end product.
  2. Development of hyperuricemia. This is the logical consequence of the first stage. The term refers to a persistent, pathologic increase in blood uric acid levels, supersaturating the blood.
  3. Tissue crystal precipitation. Because the blood's capacity to dissolve uric acid is limited, the excess begins to crystallize. Salts precipitate and accumulate in various organs and tissues, causing cellular injury.

Clinical and Morphological Manifestations

When uric acid salts begin to deposit in tissues, specific diseases develop. In pathology, three main forms of this disorder are distinguished:

Gout: The Classic Purine Imbalance

Gout (Gout) is the most prominent manifestation of disordered nucleoprotein metabolism. The term originates from two Greek words: podos ("foot") and agra ("trap"). This vividly describes a patient's sensations during a pain attack—as if the foot is caught in a steel vise.

By definition, gout is a disease characterized by intermittent precipitation of monosodium urate crystals, localized primarily in the joints. The crystallization and deposition process is invariably accompanied by severe, acute pain.

In medical classification, gout is divided into primary and secondary forms. Acute and chronic clinical courses are also distinguished.

Mnemonic

To remember the essence of gout forever, recall its etymology: podos — foot, agra — trap. A "foot in a trap" is the ideal association for the acute pain of monosodium urate crystals piercing a joint.

Frequently asked questions

What morphological changes develop in joints during chronic gout?

Chronic gout causes destructive and inflammatory changes in joints, leading to deformation. Key morphological features include:

  • Tophi (tophi urici) — gouty nodules representing focal crystalline aggregates.
  • Necrosis — zones of tissue death surrounding monosodium urate crystals.
  • Inflammatory infiltrate — a perifocal granulomatous reaction around crystals containing foreign-body multinucleated giant cells.
  • Sclerosis — proliferation of connective tissue around the lesion as an outcome of chronic productive inflammation.

Deposits localize in the synovium, articular cartilage, bursae, and tendons.

What is the macroscopic and microscopic picture of a renal uric acid infarct?

The morphological substrate of a renal uric acid infarct consists of microscopic precipitation of uric acid crystals within renal tubules. These crystalline masses extend from the renal pyramids toward the cortex. Clinically, the condition presents with turbid reddish urine that leaves distinctive brownish-red stains on linens.

What are the primary causes of secondary gout?

Secondary gout develops as a consequence of other diseases or external factors leading to hyperuricemia. Main causes include:

  • Hematopoietic disorders and accelerated cell turnover — myelogenous leukemias, hemoglobinopathies, and chronic hemolysis.
  • Other disorders — psoriasis and endocrine conditions.
  • Iatrogenic factors — cytostatic therapy, long-term diuretic use, and low-dose acetylsalicylic acid.
  • Decreased uric acid excretion — chronic kidney disease, renal pathologies leading to nephrosclerosis.
  • Toxic exposures — alcohol and lead.
How does primary gout differ from secondary gout?

The main difference lies in etiology and the mechanisms of hyperuricemia.

FeaturePrimary (Idiopathic) GoutSecondary Gout
EtiologyGenetically determined enzyme anomaly of purine metabolism.Consequence of other diseases or external exposures.
MechanismSpecific enzyme defects lead to excessive uric acid accumulation.Accelerated cell breakdown (e.g., in leukemias) or decreased uric acid excretion.
Risk FactorsExcessive consumption of meat and purine-rich foods.Tumors, renal diseases, endocrine pathologies, toxic and iatrogenic factors.
What organs and tissues, besides joints, are affected in gout?

Besides joints, gout affects soft tissues, skin, kidneys, urinary tract, and the heart.

  • Kidneys and urinary tract — gouty nephropathy develops, with urates depositing in the interstitium, tubular epithelium, renal pelves, ureters, and bladder.
  • Skin and subcutaneous tissue — tophi form with urate deposition in areas of dermal necrosis (often on the auricles, fingers, and toes).
  • Periarticular tissues — tendons and bursae become involved.
  • Heart — the disease can lead to secondary metabolic cardiomyopathy.
What are nucleoproteins made of and where do they come from?

Nucleoproteins are complexes of protein and nucleic acids (DNA and RNA). They enter the body exogenously (via diet) and are also produced through endogenous intracellular synthesis.

What is the end product of nucleic acid metabolism?

The metabolism of nucleic acids (purine metabolism) yields uric acid and its salts. Normally, these substances are freely excreted by the kidneys.

How does pathology develop during this metabolic failure?

Pathogenesis consists of three steps. First, excessive uric acid production occurs. Next, hyperuricemia develops—an elevated blood level of this acid. Finally, excess salts precipitate in various tissues.

Why is gout named that way and what is its core mechanism?

The term comes from the Greek words podos (foot) and agra (trap). The core mechanism involves intermittent precipitation of monosodium urate crystals in joints, triggering severe pain as if the foot were trapped.

Go deeper

More topics in Pathology

Heart Transplantation: Pathology, Rejection, and ComplicationsMyeloma KidneyGastritis: Acute and Chronic Forms, OLGA SystemHepatoblastoma and Vascular Liver TumorsMalariaChronic Lymphocytic LeukemiaArterial DiseasesHelicobacter pylori: Pathogenesis and Clinical OutcomesSecondary Liver TumorsAmebiasisEpithelial TumorsCalculosisPathology →